Prescient Therapeutics (ASX: PTX) Share Price

PTX

$0.068▼-2.86%

$71.5MRank #922 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$71.5M

Volume

420K

P/E Ratio

-5.28

EPS

-$0.004

Dividend Yield

0.00%

52-Week High

$0.125

52-Week Low

$0.04

Beta

0.492

Prescient Therapeutics (ASX: PTX) is an Australian-listed company in the Healthcare sector with a market capitalisation of $71.5M and the 922nd-largest security on the ASX by market capitalisation. The PTX share price is $0.068, down 2.86% today and up 28.30% over the past 12 months. Shares have traded between $0.04 and $0.125 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Prescient Therapeutics reported revenue of $0 and a net loss of $4.0M.

Charts

$0.07

24H Range

$0.066

$0.07

52-Week Range

$0.04

$0.125

About Prescient Therapeutics Limited

Prescient Therapeutics Limited (PTX.AX) is an Australian clinical-stage oncology firm dedicated to creating novel therapeutic agents for various cancer types. The company's primary experimental compound, PTX-200, is currently undergoing several clinical trials: Phase 2a for HER2-negative breast cancer, Phase 1B/2 for acute myeloid leukemia that has relapsed or is resistant to treatment, and Phase 1b for ovarian cancer that is recurrent, persistent, or resistant to platinum-based therapies. Additionally, PTX-100, a RhoA inhibitor, is being developed to target both blood cancers and solid tumors, specifically those characterized by Ras and RhoA genetic mutations. Prescient Therapeutics has also forged a strategic alliance with The University of Texas MD Anderson Cancer Center to advance the development of a blood cancer binder for their OmniCAR platform. Founded in Melbourne, Australia, in 1986, the company operated as Virax Holdings Limited until its rebranding as Prescient Therapeutics Limited in December 2014.

IPO Date

3 Jan 1999

CEO

James McDonnell

Employees

Website

ptxtherapeutics.com

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-4.0M
Total Assets	$18.5M
Total Debt	$495,886
Free Cash Flow	$-6.5M
Return on Equity	-23.49%
Profit Margin	—
Operating Margin	—

PTX Frequently Asked Questions

What is the Prescient Therapeutics (ASX: PTX) share price?

The PTX share price is $0.068, down 2.86% for the day, based on the latest available ASX market data.

What is Prescient Therapeutics's market capitalisation?

Prescient Therapeutics has a market capitalisation of $71.5M, making it the 922nd-largest security listed on the ASX.

Does Prescient Therapeutics pay a dividend?

PTX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Prescient Therapeutics profitable?

In its most recent reported period (ending 31 Dec 2025), PTX reported revenue of $0 and a net loss of $4.0M.

How many PTX shares are on issue?

Prescient Therapeutics has approximately 1,051,514,544 shares on issue, based on its market capitalisation of $71.5M and current share price.

What sector is Prescient Therapeutics in?

Prescient Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Prescient Therapeutics list on the ASX?

Prescient Therapeutics listed on the Australian Securities Exchange on 3 Jan 1999.

Latest News

Prescient appoints oncology drug development veteran Dr Rosalind Wilson as chief medical officer

Proactive financial news11 June 2026

Prescient appoints oncology drug development veteran Dr Rosalind Wilson as chief medical officer Proactive financial news

Prescient Therapeutics welcomes chief medical officer

grafa.com11 June 2026

Prescient Therapeutics welcomes chief medical officer grafa.com

Insights: Prescient Therapeutics Ltd (ASX:PTX)

smallcaps.com.au30 Oct 2025

Insights: Prescient Therapeutics Ltd (ASX:PTX) smallcaps.com.au

Why Did Prescient (ASX:PTX) Share Price Fall 9% Today?

Kalkine9 Apr 2026

Why Did Prescient (ASX:PTX) Share Price Fall 9% Today? Kalkine

Prescient Therapeutics Shares Surge on EU Orphan Drug Designation

thebull.com.au19 Nov 2025

Prescient Therapeutics Shares Surge on EU Orphan Drug Designation thebull.com.au

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
ADOAnteoTech Limited	$78.2M	$0.024	-10.60	0.00%	▼-7.69%
CYPCynata Therapeutics Limited	$63.3M	$0.26	-7.57	0.00%	–+0.00%
ATXAmplia Therapeutics Limited	$56.5M	$0.11	-8.54	0.00%	–+0.00%
RADRadiopharm Theranostics Limited	$47.3M	$0.02	-0.82	0.00%	▲+5.26%
IIQINOVIQ Ltd	$36.8M	$0.315	-3.02	0.00%	–+0.00%
NOXNoxopharm Limited	$23.7M	$0.077	-3.69	0.00%	▼-3.75%
NSBNeuroScientific Biopharmaceuticals Limited	$21.9M	$0.069	-5.38	0.00%	▲+15.00%
PIQProteomics International Laboratories Limited	$20.6M	$0.125	-4.45	0.00%	–+0.00%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.069	$0.07	$0.066	$0.068	416K	▼-2.86%
11 June 2026	$0.067	$0.073	$0.067	$0.07	540K	▲+6.06%
10 June 2026	$0.068	$0.07	$0.066	$0.066	803K	▼-4.35%
9 June 2026	$0.072	$0.072	$0.064	$0.069	983K	▼-5.48%
8 June 2026	$0.072	$0.074	$0.07	$0.073	394K	▲+4.29%
5 June 2026	$0.072	$0.074	$0.07	$0.07	379K	▼-2.78%
4 June 2026	$0.071	$0.074	$0.071	$0.072	177K	–+0.00%
3 June 2026	$0.074	$0.077	$0.072	$0.072	812K	▼-2.70%
2 June 2026	$0.077	$0.077	$0.071	$0.074	1.5M	▼-5.13%
1 June 2026	$0.078	$0.079	$0.076	$0.078	1.5M	–+0.00%
29 May 2026	$0.078	$0.081	$0.076	$0.078	920K	▲+1.30%
28 May 2026	$0.078	$0.08	$0.076	$0.077	377K	▼-1.28%
27 May 2026	$0.078	$0.08	$0.078	$0.078	377K	▲+1.30%
26 May 2026	$0.076	$0.081	$0.076	$0.077	1.1M	▼-1.28%
25 May 2026	$0.085	$0.088	$0.076	$0.078	3.6M	▼-2.50%
22 May 2026	$0.072	$0.08	$0.071	$0.08	2M	▲+9.59%
21 May 2026	$0.068	$0.073	$0.067	$0.073	483K	▲+12.31%
20 May 2026	$0.07	$0.07	$0.064	$0.065	1.2M	▼-9.72%
19 May 2026	$0.069	$0.073	$0.069	$0.072	1.3M	▲+7.46%
18 May 2026	$0.067	$0.068	$0.064	$0.067	831K	▲+3.08%
15 May 2026	$0.07	$0.07	$0.064	$0.065	1.2M	▼-2.99%
14 May 2026	$0.057	$0.077	$0.057	$0.067	3.7M	▲+19.64%
13 May 2026	$0.055	$0.056	$0.055	$0.056	173K	▲+3.70%
12 May 2026	$0.055	$0.055	$0.053	$0.054	259K	▲+1.89%
11 May 2026	$0.053	$0.055	$0.053	$0.053	164K	▼-1.85%
8 May 2026	$0.053	$0.054	$0.053	$0.054	82K	▼-1.82%
7 May 2026	$0.052	$0.055	$0.052	$0.055	609K	▲+7.84%
6 May 2026	$0.053	$0.053	$0.051	$0.051	939K	▼-5.56%
5 May 2026	$0.053	$0.054	$0.051	$0.054	1M	–+0.00%
4 May 2026	$0.054	$0.055	$0.054	$0.054	397K	–+0.00%

About Prescient Therapeutics Limited

IPO Date

3 Jan 1999

CEO

James McDonnell

Employees

Website

ptxtherapeutics.com

PTX Frequently Asked Questions

What is the Prescient Therapeutics (ASX: PTX) share price?

The PTX share price is $0.068, down 2.86% for the day, based on the latest available ASX market data.

What is Prescient Therapeutics's market capitalisation?

Prescient Therapeutics has a market capitalisation of $71.5M, making it the 922nd-largest security listed on the ASX.

Does Prescient Therapeutics pay a dividend?

PTX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Prescient Therapeutics profitable?

In its most recent reported period (ending 31 Dec 2025), PTX reported revenue of $0 and a net loss of $4.0M.

How many PTX shares are on issue?

Prescient Therapeutics has approximately 1,051,514,544 shares on issue, based on its market capitalisation of $71.5M and current share price.

What sector is Prescient Therapeutics in?

Prescient Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Prescient Therapeutics list on the ASX?

Prescient Therapeutics listed on the Australian Securities Exchange on 3 Jan 1999.

Company

Market Cap

Price

P/E

Div Yield

1D Change

ADOAnteoTech Limited

$78.2M

$0.024

-10.60

0.00%

▼-7.69%

CYPCynata Therapeutics Limited

$63.3M

$0.26

-7.57

0.00%

–+0.00%

ATXAmplia Therapeutics Limited

$56.5M

$0.11

-8.54

0.00%

–+0.00%

RADRadiopharm Theranostics Limited

$47.3M

$0.02

-0.82

0.00%

▲+5.26%

IIQINOVIQ Ltd

$36.8M

$0.315

-3.02

0.00%

–+0.00%

NOXNoxopharm Limited

$23.7M

$0.077

-3.69

0.00%

▼-3.75%

NSBNeuroScientific Biopharmaceuticals Limited

$21.9M

$0.069

-5.38

0.00%

▲+15.00%

PIQProteomics International Laboratories Limited

$20.6M

$0.125

-4.45

0.00%

–+0.00%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.069	$0.07	$0.066	$0.068	416K	▼-2.86%
11 June 2026	$0.067	$0.073	$0.067	$0.07	540K	▲+6.06%
10 June 2026	$0.068	$0.07	$0.066	$0.066	803K	▼-4.35%
9 June 2026	$0.072	$0.072	$0.064	$0.069	983K	▼-5.48%
8 June 2026	$0.072	$0.074	$0.07	$0.073	394K	▲+4.29%
5 June 2026	$0.072	$0.074	$0.07	$0.07	379K	▼-2.78%
4 June 2026	$0.071	$0.074	$0.071	$0.072	177K	–+0.00%
3 June 2026	$0.074	$0.077	$0.072	$0.072	812K	▼-2.70%
2 June 2026	$0.077	$0.077	$0.071	$0.074	1.5M	▼-5.13%
1 June 2026	$0.078	$0.079	$0.076	$0.078	1.5M	–+0.00%
29 May 2026	$0.078	$0.081	$0.076	$0.078	920K	▲+1.30%
28 May 2026	$0.078	$0.08	$0.076	$0.077	377K	▼-1.28%
27 May 2026	$0.078	$0.08	$0.078	$0.078	377K	▲+1.30%
26 May 2026	$0.076	$0.081	$0.076	$0.077	1.1M	▼-1.28%
25 May 2026	$0.085	$0.088	$0.076	$0.078	3.6M	▼-2.50%
22 May 2026	$0.072	$0.08	$0.071	$0.08	2M	▲+9.59%
21 May 2026	$0.068	$0.073	$0.067	$0.073	483K	▲+12.31%
20 May 2026	$0.07	$0.07	$0.064	$0.065	1.2M	▼-9.72%
19 May 2026	$0.069	$0.073	$0.069	$0.072	1.3M	▲+7.46%
18 May 2026	$0.067	$0.068	$0.064	$0.067	831K	▲+3.08%
15 May 2026	$0.07	$0.07	$0.064	$0.065	1.2M	▼-2.99%
14 May 2026	$0.057	$0.077	$0.057	$0.067	3.7M	▲+19.64%
13 May 2026	$0.055	$0.056	$0.055	$0.056	173K	▲+3.70%
12 May 2026	$0.055	$0.055	$0.053	$0.054	259K	▲+1.89%
11 May 2026	$0.053	$0.055	$0.053	$0.053	164K	▼-1.85%
8 May 2026	$0.053	$0.054	$0.053	$0.054	82K	▼-1.82%
7 May 2026	$0.052	$0.055	$0.052	$0.055	609K	▲+7.84%
6 May 2026	$0.053	$0.053	$0.051	$0.051	939K	▼-5.56%
5 May 2026	$0.053	$0.054	$0.051	$0.054	1M	–+0.00%
4 May 2026	$0.054	$0.055	$0.054	$0.054	397K	–+0.00%